24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma.
Τίτλος | 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma. |
Publication Type | Journal Article |
Year of Publication | 2010 |
Authors | Konstas, A. G. P., Mikropoulos D. G., Embeslidis T. A., Dimopoulos A. T., Papanastasiou A., Haidich A-B., & Stewart W. C. |
Journal | Eye (Lond) |
Volume | 24 |
Issue | 10 |
Pagination | 1606-13 |
Date Published | 2010 Oct |
ISSN | 1476-5454 |
Λέξεις κλειδιά | Aged, Antihypertensive Agents, Cloprostenol, Cross-Over Studies, Drug Administration Schedule, Drug Therapy, Combination, Exfoliation Syndrome, Female, Glaucoma, Humans, Intraocular Pressure, Male, Middle Aged, Prospective Studies, Prostaglandins F, Synthetic, Single-Blind Method, Time Factors, Timolol |
Abstract | PURPOSE: To evaluate 24-h efficacy of travoprost/timolol fixed combination (TTFC) vslatanoprost/timolol fixed combination (LTFC) in exfoliative glaucoma (XFG).DESIGN: A prospective, single-masked, crossover, active-controlled, randomized 24-h comparison.METHODS: After up to a 6-week medicine-free period, XFG patients were randomized to either TTFC or LTFC for 3 months, dosed each evening, and then changed to the opposite treatment for another 3 months. At the end of the washout, and both treatment periods, a 24-h intraocular pressure (IOP) curve was measured.RESULTS: In total, 40 patients completed the study. The TTFC group showed a lower mean absolute 24-h IOP (18.7±2.6 vs 19.6±2.6 mm Hg, P<0.001), maximum IOP (20.5±2.6 vs 21.5±2.6 mm Hg, P<0.001) and 24-h IOP range (3.4±1.3 vs 4.1±1.6 mm Hg, P=0.01). At individual time points, TTFC showed reduced IOPs compared with LTFC, after a Bonferroni correction, at 1000, 1800, and 2200 hours (P≤0.04). No statistical differences existed at hours: 0600, 1400, and 0200 (P≥0.05) and for the minimum IOP (P=0.09).CONCLUSIONS: This study suggests that evening-dosed TTFC may provide greater 24-h IOP reduction, primarily at the 1800 hours time point, compared with LTFC in XFG. |
DOI | 10.1038/eye.2010.100 |
Alternate Journal | Eye (Lond) |
PubMed ID | 20651749 |